Table 2.

Effect of corilagin on passive cutaneous anaphylaxis, active anaphylaxis and degranulation of mast cell.

Sr. No.	Group		Passive cutaneous anaphylaxis		Active anaphylaxis	Mast cell degranulation
			Blueing reaction mm3	Behavioural symptoms (% of mortality)	Respiratory score	Intact	Degranulated
1	Control		00	Normal	00 (00)	100	00
2	Negative control		78.39±3.15	Respiratory distress/collapse 3–5 min (70%)	8.80±5.2 (65%)	22.62±2.94##	79.32±4.72##
3	Corilagin 10 mg/kg		69.17±3.09	Dysponea 5–8 min (40%)	6.25±3.15 (40%)	31.72±2.45*	67.37±4.31**
4	Corilagin 20 mg/kg		54.92±2.90	Dysponea 15–20 min (25%)	4.10±1.28 (25%)	43.89±3.56**	56.18±3.78**
5	Corilagin 40 mg/kg		47.36±1.97	Normal	2.74±1.45 (15%)	55.73±4.71**	44.27±3.26**
6	STD	Dexomethasone	43.18±2.69	Normal	2.36±0.75 (15%)	–	–
		Ketotifen	–	–	–	62.39±4.26**	38.29±2.46**

Means ±SD (n=6),

^##p<0.01 than control,

^*p<0.05,

^**p<0.01 than negative control.